Activation of the MEK–S6 Pathway in High-Grade Ovarian Cancers
Applied Immunohistochemistry and Molecular Morphology - United States
doi 10.1097/pai.0b013e3181e53e1c
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2010
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)